Showing results (71-80 of 175) with videos related to
Sort By:
Pageof 18
Fundamental & Clinical Pharmacology|January 1, 1997
A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placeboM Bourin, T Bougerol, B Guitton, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 13, 2000
Effect of CCK-4 on a 35% carbon dioxide challenge in healthy volunteersH Pols, E Griez, M Bourin, et al.Neuroscience and Biobehavioral Reviews|March 12, 1999
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humansK M Hegadoren, G B Baker, M BourinFundamental & Clinical Pharmacology|January 1, 1996
Two faces of cholecystokinin: anxiety and schizophreniaM Bourin, M Malinge, E Vasar, et al.Psychopharmacology|May 5, 1998
Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming testM Bourin, J P Redrobe, G B BakerPharmacology, Biochemistry, and Behavior|January 4, 1998
Influence of prior experience on mice behavior using the four-plate testM Hascoet, M Bourin, A Couetoux du TertreArzneimittel-Forschung|January 1, 1983
The value of the reserpine test in psychopharmacologyM Bourin, M Poncelet, R Chermat, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
The mouse light-dark paradigm: a reviewM Hascoët, M Bourin, B A Nic DhonnchadhaMethods and Findings in Experimental and Clinical Pharmacology|May 1, 1985
Theoretical study of haemoperfusion: drugs obeying a one-compartment pharmacokinetics modelJ Guenzet, M Bourin, D Laurent, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 1, 1995
[Experimental and clinical pharmacology of psychostimulants]M Bourin, J M Le Melledo, M MalingePageof 18